Efficacy News and Research

RSS

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

Vaccines can be made over 25% more effective by adding left-handed chiral gold nanoparticles as adjuvants, according to a study by an international collaboration in which Brazilian researchers took part. An article reporting the results is published in Nature.

18 Apr 2022

New poll reaffirms picky eating as a universal parenting challenge

Kids can be stubborn when it comes to eating the healthy foods on their plate.

18 Apr 2022

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Researchers assessed the effectiveness of COVID-19 vaccines against related hospitalizations and death.

18 Apr 2022

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

A new study explores the possibility that different statins may exhibit different effects within the host and may differ in their outcomes while treating COVID-19 patients.

18 Apr 2022

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Researchers reviewed the antibody resistance exhibited by SARS-CoV-2 variants.

18 Apr 2022

Monoclonal antibodies from COVID-19 convalescent donors target conserved site

Researchers found six monoclonal antibodies binding to the spike proteins of all human coronaviruses.

18 Apr 2022

RNA interference triggers that target SARS-CoV-2 genome

Researchers screened ribonucleic acid interference against SARS-CoV-2.

18 Apr 2022

Impact of COVID-19 booster vaccination campaign in Israel

Researchers assess the implications of the COVID-19 booster vaccine on the Israeli population.

18 Apr 2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Researchers investigated the longevity and intensity of the SARS-CoV-2 vaccine immune response in patients suffering from immune-mediated inflammatory diseases.

15 Apr 2022

A comprehensive rule book for the design of safe and efficient therapeutic cells

Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer.

15 Apr 2022

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

A booster dose of mRNA vaccine significantly decreases the risk of being infected with either the delta or omicron COVID-19 variants, according to scientists at the Rocky Mountain Center for Occupational and Environmental Health (RMCOEH), a program partnership between the University of Utah and Weber State University.

14 Apr 2022

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Researchers assessed the protective efficacy of the temperature-stable orally delivered vaccines against respiratory viral pathogens.

14 Apr 2022

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing system.

14 Apr 2022

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

A recent report suggested that a single dose of the human papillomavirus (HPV) vaccination confers equivalent immunity to a two-dose schedule against cervical cancers caused by HPV.

14 Apr 2022

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

In a recent study, researchers assessed the anti-COVID-19 efficacy of Salvia miltiorrhiza Bunge.

14 Apr 2022

Novel transdermal vaccine delivery for COVID-19 and cancer

Researchers assess the efficacy of a fluorocarbon modified chitosan system for the development of SARS-CoV-2 vaccines and tumor immunotherapy.

13 Apr 2022

Mayo Clinic researchers devise a combination approach to more effectively target solid tumors

Researchers at Mayo Clinic's Center for Individualized Medicine have devised an immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors.

13 Apr 2022

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

A new study has stated that the third booster dose of mRNA-based COVID-19 vaccines is 68% effective in preventing reinfection-related hospitalization among persons with a history of SARS-CoV-2.

13 Apr 2022

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

A recent study discusses a case report of the probable vertical transmission of tick-borne encephalitis virus (TBEV) from an unvaccinated mother to her newborn via breast milk.

13 Apr 2022

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

A recent study assessed the efficacy of the second and third doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccines against the SARS-CoV-2 Omicron and Delta variants in outpatient settings.

13 Apr 2022

Efficacy News and Research

Addition of left-handed chiral gold nanoparticles can enhance vaccine efficacy by more than 25%

New poll reaffirms picky eating as a universal parenting challenge

Study finds two doses of mRNA or ChAdOx1 vaccines provide excellent protection against severe outcomes of hospitalization and death

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

Mutation-acquiring potential of coronaviruses and efficacies of current COVID-19 vaccines against parent and mutant strains of SARS-CoV-2

Monoclonal antibodies from COVID-19 convalescent donors target conserved site

RNA interference triggers that target SARS-CoV-2 genome

Impact of COVID-19 booster vaccination campaign in Israel

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

A comprehensive rule book for the design of safe and efficient therapeutic cells

Booster dose of mRNA vaccine highly effective in preventing SARS-CoV-2 infection

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

Novel transdermal vaccine delivery for COVID-19 and cancer

Mayo Clinic researchers devise a combination approach to more effectively target solid tumors

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

Case of probable transmission of tick-borne encephalitis virus from an unvaccinated mother to an infant through breast-feeding

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News